• $18.00
    Market Cap
  • -99.99%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
28.3M
-35.08%
43.5M
-18.96%
53.7M
N/A
Cost of Revenue
35.7M
-21.31%
45.4M
-11.45%
51.2M
N/A
Gross Profit
-7.4M
+304.24%
-1.8M
-174.32%
2.5M
N/A
Sales and Marketing Expense
2.4M
-54.55%
5.3M
-38.38%
8.6M
N/A
Research and Development Expense
-78,000
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
5.1M
-30.63%
7.4M
+74.13%
4.2M
N/A
Total Operating Expenses
10.1M
-33.75%
15.3M
+240.05%
4.5M
N/A
Operating Profit
-17.6M
+2.61%
-17.1M
-1,331.37%
1.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-3.8M
-39.70%
-6.4M
N/A
N/A
N/A
Interest Income and Expense and Net
-3.8M
-39.70%
-6.4M
N/A
0
N/A
Total Nonoperating Income and Expense
-19.6M
-899.14%
2.5M
+177.64%
-3.2M
N/A
Income before Taxes
-37.2M
+52.55%
-24.4M
-1,853.45%
1.4M
N/A
Income Taxes
161,000
-15.71%
191,000
-10.33%
213,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
0
N/A
Net Income
-37.3M
+52.02%
-24.6M
-0.46%
-24.7M
N/A
Net Income from Continuing Operations Applicable to Common
-37.2M
+52.55%
-24.4M
-1.23%
-24.7M
N/A
Basic EPS and Net Income
-2.71
+1,131.82%
-0.22
-18.52%
-0.27
N/A
Diluted EPS and Net Income
-2.71
+1,131.82%
-0.22
-18.52%
-0.27
N/A
Basic Weighted Average Shares
13.8M
-87.82%
113.2M
+24.73%
90.7M
N/A
Diluted Weighted Average Shares
13.8M
-87.82%
113.2M
+24.73%
90.7M
N/A
Balance Sheet
Cash and Cash Equivalents
2.3M
+110.47%
1.1M
-86.08%
7.9M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.3M
+110.47%
1.1M
-86.08%
7.9M
N/A
Total Current Assets
12.1M
-31.17%
17.6M
-44.12%
31.4M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
4.1M
-86.90%
31.3M
-51.71%
64.8M
N/A
Total Long-Term Assets
555,000
+34.38%
413,000
-0.72%
416,000
N/A
Total Assets
37.6M
-68.35%
118.8M
-13.51%
137.4M
N/A
Income Taxes Payable
3,000
-99.68%
948,000
-66.50%
2.8M
N/A
Total Short-Term Debt
3,000
-99.99%
21.7M
+9,709.95%
221,000
N/A
Total Current Liabilities
8.6M
-71.90%
30.6M
+202.78%
10.1M
N/A
Total Long-Term Debt
0
-100.00%
3,000
-99.98%
14.0M
N/A
Total Long-Term Liabilities
0
-100.00%
52.8M
+55.20%
34.1M
N/A
Total Liabilities
26.1M
-63.04%
70.7M
+5.42%
67.1M
N/A
Retained Earnings
-181.0M
+26.00%
-143.6M
+20.63%
-119.1M
N/A
Total Stockholders Equity
11.5M
-76.15%
48.1M
-31.56%
70.3M
N/A
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-6.0M
-6.25%
-6.4M
-75.26%
-26.0M
N/A
Capital Expenditures
135,000
-96.82%
4.3M
+18.29%
3.6M
N/A
Cash from Investing Activities
-135,000
-96.78%
-4.2M
-46.08%
-7.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
7.4M
+92.17%
3.8M
-75.90%
16.0M
N/A
Financials Ratio
Gross Margin
-26.33%
+522.62%
-4.23%
N/A
N/A
N/A
Operating Margin
-62.13%
+58.04%
-39.32%
N/A
N/A
N/A
Return on Assets
-47.74%
+148.97%
-19.18%
N/A
N/A
N/A
Return on Equity
-125.32%
+202.08%
-41.48%
N/A
N/A
N/A
Revenue Growth
-35.08%
+84.96%
-18.96%
N/A
N/A
N/A
Current Ratio
1.40
+144.94%
0.57
N/A
N/A
N/A
Cash Ratio
0.27
+649.44%
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
0.0003
-99.93%
0.45
N/A
N/A
N/A
Debt-to-Assets Ratio
0.0001
-99.95%
0.18
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow